Navigation Links
Taiho Pharmaceutical présente une demande d'homologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
Date:2/26/2013

e III (RECOURSE)

L'essai clinique mondial de phase III (RECOURSE) est un essai à répartition aléatoire, mené en double insu pour comparer le TAS-102 à un placébo. Il est prévu que cet essai clinique mondial de phase III porte sur quelque 800 patients du Japon, d'Amérique du Nord, d'Europe et d'Australie. Le recrutement des patients a débuté en juin 2012. Les sujets sont des patients atteints de cancer colorectal récurrent à un stade avancé, non résécable, réfractaire aux chimiothérapies standard. Celles-ci comprennent les fluoropyrimidines, l'irinotécan, l'oxaliplatine, le bevacizumab et, chez les patients dont la tumeur abrite le gène KRAS de type sauvage, un anticorps monoclonal EGFR. Cet essai vise à comparer les patients qui sont répartis aléatoirement pour recevoir le TAS-102 ou un placébo afin d'étudier l'efficacité et l'innocuité du TAS-102. Le paramètre d'évaluation primaire est la survie globale. Les chercheurs principaux sont le Dr Atsushi Ohtsu , Directeur du Centre de développement clinique du National Cancer Center Hospital East (Japon), le Dr Robert J. Mayer du Dana Farber Cancer Institute (États-Unis) et le Dr Eric Van Cutsem de l'Hôpital universitaire de Gasthuisberg (Belgique).

À propos de Taiho Pharmaceutical Co., Ltd.

Taiho Pharmaceutical, filiale d'Otsuka Holdings Co., Ltd. (http://www.otsuka.com/en/) est une société pharmaceutique spécialisée dans la recherche et le développement et qui se concentre sur trois domaines : l'oncologie, les allergies et l'immunologie, ainsi que l'urologie. Sa philosophie d'entreprise prend la forme d'une promesse : « Nous œuvrons à l'amélioration de la santé h
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
2. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
4. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
5. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
6. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
7. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
8. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
9. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
10. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
11. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014  A decline in revenues ... are adding pressure to pharmaceutical, biotechnology and medical ... continue to shrink and approval processes and postapproval ... companies to look for additional support and expertise ... keeping approved products on the market.  ...
(Date:8/28/2014)... VIEJO , Californie, 28 août ... a annoncé aujourd,hui le début des ... d,une étude  d,exemption des dispositifs expérimentaux ... destinée à évaluer l,innocuité et l,efficacité ... (« WEB »). Le docteur Adam Arthur ...
(Date:8/28/2014)... , Aug. 28, 2014  Celsion Corporation (NASDAQ: ... company, today announced that Michael H. Tardugno , ... at the Rodman & Renshaw 16th Annual Healthcare Conference ... a.m. Eastern Time. The conference is being held at ... A copy of the presentation will be available on ...
Breaking Medicine Technology:4 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 4Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference 2
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing ... chief operations officer, will present at ThinkEquity,s Second Annual ... a.m. ET. The conference will be held at The ... About AbaxisAbaxis develops, manufactures, markets and sells portable blood ...
... presented this week at the International Federation of Clinical ... lower diagnostic threshold for troponin improves clinical outcomes and ...  Troponin is a protein found inside of heart cells ... or reduced blood supply.   Cardiac troponin ...
Cached Medicine Technology:Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 2Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 3Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 4
(Date:8/28/2014)... 2014 Following the death of an 18-year-old ... FDA issued a warning on powdered caffeine products. ... substance that is readily available to consumers, despite the fact ... senior Logan Stiner died from an overdose of caffeine powder. ... the FDA to issue a safety advisory for caffeine powders. ...
(Date:8/28/2014)... 28, 2014 Catalent Pharma Solutions, ... and development solutions for drugs, biologics and consumer ... Director Clinical Supply Services, and Chris Greco, Manager, ... Sourcing Strategies for Active Control Clinical Trials” at ... takes place on the 9th – 10th September, ...
(Date:8/28/2014)... 2014) A subset of patients with stage III ... irinotecan-based therapy, according to a new study in ... of the American Gastroenterological Association. , When added to ... adjuvant irinotecan therapy improved overall survival rates for patients ... seen in about 10 to 20 percent of colorectal ...
(Date:8/28/2014)... scientists are working out how to safely increase the ... offering improved local control and survival. , Standard treatment ... combination of radiotherapy and chemotherapy. Traditionally this is planned ... not always be enough to stop tumour growth. , ... cancerous tissue varies between patients and depends on the ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 AmeriPride Services, ... America, today announced the launch of its new Customer ... AmeriPride even easier and more convenient for customers. The ... online and better communicate with the company. , Features ... Access, download and pay bills ...
Breaking Medicine News(10 mins):Health News:FDA Issues Safety Advisory for Caffeine Powders 2Health News:Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference 2Health News:Drug shows promise for subset of stage III colon cancer patients 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3
... researchers say , SUNDAY, Nov. 18 (HealthDay News) -- ... suggests. , A U.S. team found that talking to ... and test scores. , They found that "socializing was ... exercise in boosting memory and intellectual performance," lead author ...
... costs and prepare ... covers of hospital costs and, efficiencies using more refined performance metrics ... ... A new benchmarking study was,launched today to measure the cost and efficiencies of ...
... it from spreading, expert says , , SATURDAY, Nov. 17 (HealthDay News) ... hit by the flu bug this year, but some simple precautions ... said. , The flu shot is the most effective method of ... officer at Brigham and Women,s Hospital in Boston. It,s important to ...
... Nancy Pelosi,will join Congressmen Ciro D. Rodriguez, Charlie ... the State Children,s Health,Insurance Program (SCHIP) bill that ... WHO: Speaker Nancy Pelosi Congressman Ciro D. ... Congressman Henry Cuellar (TX-28), WHAT: Rally for ...
... Nov. 16 Angel Flight West,(AFW) awarded The Distinguished ... Dan Telfair at AFW,s 24th Anniversary Awards and on ... awards event. Telfair,completed 56 missions over the past year. ... non-emergency health care problems require that they travel,to and ...
... Nov. 16 Nothing says,"Thanksgiving" like football, family and ... But no matter what,s included in a,Thanksgiving spread, one ... the American Society for Surgery of the Hand cautions,carvers ... not their own hands., Every year during Thanksgiving, ...
Cached Medicine News:Health News:Talking With Others May Make You Smarter 2Health News:Global Health Support Service Benchmark Study to Combat Growing Healthcare Costs and Prepare for Likely Health Care Reforms 2Health News:Angel Flight West Recognizes New Mexico Pilots and Receives Grant to Improve Access to Health Care 2Health News:Holiday Hand Safety 101: Hand Surgeons Offer Tips for a Safe Carving Season 2
For Atrial Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters. The CRISTA CATH 20-pole deflectable catheter is designed for positioning along the crista terminals....
... Inquiry H Steerable Catheter. Steerable ... variety of designs and a ... stability. 10 to 24 electrodes, ... inactive and active tip electrodes, ...
Sophisticated DecaPolar Catheters provide enhanced recording and mapping quality....
... Torqr Quadripolar Braided Shaft ... The Medtronic CardioRhythm Torqr ... use in diagnostic electrophysiologic ... designed for recording intracardiac ...
Medicine Products: